title: Response to commentaries on the Canadian Network for Mood and Anxiety Treatments/International Society for Bipolar Disorders 2013 updated bipolar disorder guidelines.
authors.forename: Ayal
authors.initials: A
authors.lastname: Schaffer
authors.forename: Sagar V
authors.initials: SV
authors.lastname: Parikh
authors.forename: Sidney H
authors.initials: SH
authors.lastname: Kennedy
authors.forename: Roumen
authors.initials: R
authors.lastname: Milev
authors.forename: Benicio N
authors.initials: BN
authors.lastname: Frey
authors.forename: Benjamin I
authors.initials: BI
authors.lastname: Goldstein
authors.forename: Serge
authors.initials: S
authors.lastname: Beaulieu
authors.forename: Martin
authors.initials: M
authors.lastname: Alda
authors.forename: Claire
authors.initials: C
authors.lastname: O'Donovan
authors.forename: Glenda
authors.initials: G
authors.lastname: MacQueen
authors.forename: Roger S
authors.initials: RS
authors.lastname: McIntyre
authors.forename: Verinder
authors.initials: V
authors.lastname: Sharma
authors.forename: Arun
authors.initials: A
authors.lastname: Ravindran
authors.forename: L Trevor
authors.initials: LT
authors.lastname: Young
authors.forename: David J
authors.initials: DJ
authors.lastname: Bond
authors.forename: Raymond W
authors.initials: RW
authors.lastname: Lam
authors.forename: Lakshmi N
authors.initials: LN
authors.lastname: Yatham
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000379:methods* / Q000592:standards*; D019317:Evidence-Based Medicine / Q000592:standards*; D017408:Guidelines as Topic / Q000592:standards*; D006801:Humans
chemical_list: D000928:Antidepressive Agents